moderna covid vaccine

News

Moderna’s stock takes a hit

What are mRNA vaccines, and what is the impact of RFK Jr. slashing $500M to research them?

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists say the vaccines are safe.

BBC on MSN · 2d

RFK Jr cancels $500m in funding for mRNA vaccines for diseases like Covid

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being developed to counter viruses that cause diseases such as the flu and Covid-19.

MarketWatch on MSN · 2d

Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop funding mRNA drug development.

1don MSN

Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Science News4y

How the FDA-authorized Moderna COVID-19 vaccine compares to Pfizer’s ...

A second coronavirus vaccine has now joined the fight against COVID-19 in the United States. On December 18, the U.S. Food and Drug Administration authorized Moderna’s vaccine for emergency ...

CNN3y

Moderna says its Covid-19 vaccine performs as well in children as it ...

Moderna also announced that it has initiated a submission to the FDA for emergency use authorization of the company’s Covid-19 vaccine for children ages 6 through 11 years old. Children that age ...

Los Angeles Times4y

Moderna vaccine protects against COVID for months, company says - Los ...

COVID vaccine maker Pfizer Inc. lost 0.6%, while its partner BioNTech, shed 3.8%. Moderna’s latest efficacy data hasn’t been published in a medical journal and further details weren’t released.

USA Today4y

Moderna COVID-19 vaccine 94.5% effective, similar to Pfizer: Trial

Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.

The New York Times4y

Moderna's Covid-19 Vaccine, Explained - The New York Times

Moderna’s Covid Vaccine: What You Need to Know Denise Grady Published Nov. 16, 2020 Updated Nov. 30, 2020 Share full article ...

NPR4y

Moderna's COVID-19 Vaccine Candidate Gets More Good News

Coronavirus Updates What It Was Like To Participate In The Clinical Trial For Moderna's COVID-19 Vaccine Pfizer applied for emergency use authorization on Nov. 9 for its COVID-19 vaccine.

US rejection of mRNA vaccines shows ‘lack of respect for science,’ says Nobel laureate

The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results